Effect of common CYP3A4 and CYP3A5 variants on the pharmacokinetics of the cytochrome P450 3A phenotyping probe midazolam in cancer patients
Erin R Lepper, Sharyn D Baker, Matt Permenter, Nicole Ries, Ron H N van Schaik, Paul W Schenk, Douglas K Price, Danielle Ahn, Nicola F Smith, George Cusatis, Roxann G Ingersoll, Susan E Bates, Ron H J Mathijssen, Jaap Verweij, William D Figg, Alex Sparreboom
Research output: Contribution to journal › Article › Academic › peer-review
67Citations
(Scopus)
Fingerprint
Dive into the research topics of 'Effect of common CYP3A4 and CYP3A5 variants on the pharmacokinetics of the cytochrome P450 3A phenotyping probe midazolam in cancer patients'. Together they form a unique fingerprint.